Stephanie Kjærulff Holm

Stephanie Kjærulff Holm

PhD fellow

  • Clemmensen Group

    Blegdamsvej 3B, Mærsk Tårnet, 6. sal, 2200 København N.

Member of:


    Publication year:
    All
    1 - 2 out of 2Page size: 10
    Sort by: Title
    1. Published

      Beta-Hydroxybutyrate Suppresses Hepatic Production of the Ghrelin Receptor Antagonist LEAP2

      Holm, Stephanie Kjærulff, Husted, Anna Sofie, Skov, Louise Julie, Morville, T. H., Hagemann, C. A., Jorsal, T., Dall, M., Jakobsen, A., Klein, A. B., Treebak, Jonas Thue, Knop, Filip Krag, Schwartz, Thue W., Clemmensen, Christoffer & Holst, Birgitte, 2022, In: Endocrinology. 163, 6, 13 p., bqac038.

      Research output: Contribution to journal › Journal article › Research › peer-review

    2. Published

      LEAP2 reduces postprandial glucose excursions and ad libitum food intake in healthy men

      Hagemann, C. A., Jensen, M. S., Holm, Stephanie Kjærulff, Gasbjerg, Lærke Smidt, Byberg, Sarah, Skov-Jeppesen, Kirsa, Hartmann, Bolette, Holst, Jens Juul, Dela, Flemming, Vilsbøll, Tina, Christensen, Mikkel Bring, Holst, Birgitte & Knop, Filip Krag, 2022, In: Cell Reports Medicine. 3, 4, 100582.

      Research output: Contribution to journal › Journal article › Research › peer-review

    ID: 250853938